SGEN | Seagen Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	228.74 - 228.96
52 Week Range	126.47 - 228.96
Beta	0.16
Implied Volatility	3.89%
IV Rank	0.60%
Day's Volume	19,392,808
Average Volume	1,634,027
Shares Outstanding	188,663,008
Market Cap	43,154,776,450
Sector	Healthcare
Industry	Biotechnology
IPO Date	2001-03-09

Valuation
Profitability
Growth
Health
P/E Ratio	-57.19
Forward P/E Ratio	-67.06
EPS	-4.00
1YR Price Target	229.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	3,256
Country	USA
Website	SGEN

Seagen is a global biotechnology company dedicated to developing revolutionary therapies with real impact.

SGEN's peers: ALNY, ARGX, BMRN, EXEL, HALO, IONS, JAZZ, LEGN, NVO, TECH, VRTX, ZLAB

*Chart delayed

Analyzing fundamentals for SGEN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very good and Health is passable. For more detailed analysis please see SGEN Fundamentals page.

Watching at SGEN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on SGEN Technicals page.